The Oklahoma Medical Research Foundation today announced the addition of four scientists to the faculty of its Arthritis & Immunology Research Program. The four new faculty members are Patrick Gaffney, M.D., Kathy Moser, Ph.D., Jonathan Wren, Ph.D., and Igor Dozmorov, Ph.D. “Their recruitment gives us a depth of scientific commitment and expertise that is unparalleled […]
scientist-news
Putnam City students donate $116,000 to cancer research at OMRF
The bake sales have passed. The carnival games have ended. But the $116,000 that Putnam City students raised in 2006-07 will make a difference for years to come in supporting cancer research the Oklahoma Medical Research Foundation. The school district Monday night presented OMRF with the money, which was collected through a series of student […]
Pedaling for a cure: Star Bike Ride to benefit MS research
For the past six years, DeeAnn Simpson has watched from the sidelines as bicyclists peddled in a charity ride for multiple sclerosis research at the Oklahoma Medical Research Foundation. This year, though, Simpson, the event’s organizer, also plans to hop on her own bike to join in the fight against MS. “My sons and I […]
OMRF scientists present at International Congress on Lupus
A pair of physician-scientists from the Oklahoma Medical Research Foundation presented papers at the 8th annual International Congress on Lupus in Shanghai, China, last week. OMRF’s Joan Merrill, M.D., and John Harley, M.D., Ph.D., each gave invited presentations at the four-day conference, which focuses on the autoimmune disease lupus. More than 1,500 researchers, clinicians, scientists, […]
OMRF to honor scientists, board member
The Oklahoma Medical Research Foundation will honor a pair of scientists and a board member at its annual honors and awards banquet Tuesday. For the first time in OMRF’s 61-year history, the event will be held in Tulsa, at historic Cain’s Ballroom. OMRF will award Linda Thompson, Ph.D., the Edward L. and Thelma Gaylord Prize […]
FDA approves Protein C deficiency drug with OMRF roots
The U.S. Food and Drug Administration (FDA) has approved a new drug that has its origins at the Oklahoma Medical Research Foundation as the first biologic treatment for patients with a rare genetic defect that can cause a potentially life-threatening clotting disorder. The drug is a treatment for patients with complications related to severe congenital […]
